Compass Therapeutics, Inc.

CMPX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001738021

Price chart

Open-market purchases and sales by CMPX insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 25, 20268:01 AM ETSep 24, 2026Lerner NeilChief Accounting OfficerPPurchaseCommon Stock+2.5K$1.14+$2.85K400K+0.6%SEC
Apr 30, 2026AmendedApr 29, 2026Lerner NeilChief Accounting OfficerPPurchaseCommon Stock+15K$1.89+$28.35K397.5K+3.9%SEC
Apr 30, 2026AmendedApr 29, 2026Anderman JonathanGeneral CounselPPurchaseCommon Stock+25K$1.89+$47.25K196K+14.6%SEC
May 27, 2025May 27, 2025Schuetz Thomas J.CHIEF EXECUTIVE OFFICERPPurchaseCommon Stock+10K$2.11+$21.1K6.48M+0.2%SEC
Apr 11, 20257:24 PM ETApr 9, 2025ORBIMED ADVISORS LLC and 2 othersDirector, 10% OwnerSSaleCommon Stock−3.57M$1.59−$5.68M0−100.0%SEC

The largest institutional positions in CMPX at the end of Q2 2026.

Institutions holding CMPX in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
TANG CAPITAL MANAGEMENT LLC17,990,782$39.4M1.79%+1,199,973+7.1%Added
ORBIMED ADVISORS LLC15,219,994$33.33M0.63%00.0%Unchanged
SUVRETTA CAPITAL MANAGEMENT, LLC14,101,159$30.88M0.65%−206,220−1.4%Reduced
BlackRock, Inc.11,281,781$24.71M0.00%+1,775,701+18.7%Added
STATE STREET CORP9,953,653$21.8M0.00%+3,258,677+48.7%Added